Chemical Exfoliant Trends - April 2026

The chemical exfoliant category is undergoing a profound transformation, with a clear pivot towards gentler, more holistic skincare solutions. Current top trends include Polyhydroxy Acids (PHAs) for gentle exfoliation, scoring 92, and Enzyme-Based Exfoliants at 88, both reflecting a consumer desire for efficacy without irritation. Buffered & Gentle AHAs (85) and Bio-Fermented & Microbiome-Friendly ingredients (83) further underscore this shift towards skin barrier support. Emerging trends like Regenerative Actives (95) and the 'Skinification of hair' (90) signal future innovation, extending exfoliation benefits beyond the face. Conversely, harsh scrubs and high-strength exfoliants (25) and the 'freeze, peel, and purge' philosophy (30) are rapidly fading, indicating a market rejection of aggressive treatments. This trend trajectory highlights a competitive divide: emerging brands like Medicube and Anua are rapidly gaining share by embracing these new directions, while fast followers such as L'Oreal and Unilever are adapting, and slow movers like Proactiv and Biore risk falling further behind by clinging to outdated approaches.

The chemical exfoliant market remains concentrated among a few dominant players, with L'Oreal holding the largest share at 18.7%, followed by Estee Lauder at 15.2%, and Shiseido at 12.9%. Unilever (10.5%) and Beiersdorf (8.1%) also maintain significant positions, but the competitive dynamics are shifting. While the overall market share for the top brands is substantial, the strong momentum of private label brands, graded A-, indicates increasing pressure on established players to differentiate beyond brand recognition. The raw market share of 22.3% for the month, compared to an adjusted 22.8%, suggests minimal seasonal distortion on overall category share. Notably, legacy brands like Proactiv (38) and Biore (35) are identified as slow movers, struggling to adapt to the consumer demand for gentler, more sophisticated formulations, while emerging brands like Medicube and Anua are rapidly capturing new segments.

The chemical exfoliant category recorded an unadjusted market size of $0.142 billion in April, reflecting a month-over-month increase from March's $0.140 billion. The unadjusted year-to-date market reached $0.555 billion, which is below last year's $1.014 billion for the same period. However, when adjusted for seasonality, the category stands at $0.140 billion for April, contributing to an adjusted YTD total of $1.14 billion, up from $1.06 billion last year. This growth is primarily driven by a shift in consumer preference towards higher-value, gentle formulations, rather than pure volume increases. Historically, April is a relatively strong month, with the market typically rebounding further in September ($140 million) and peaking in October ($145 million), suggesting a strong finish to the year is anticipated.

Consumers in the chemical exfoliant category are highly informed and discerning, prioritizing specific outcomes and ingredient profiles. The top jobs-to-be-done include achieving 'glowy, dewy skin' (A), treating acne, pores, and preventing issues (A-), and critically, repairing and strengthening the skin barrier (A). Gentle, effective exfoliation without irritation also scores an A, underscoring the shift away from harsh treatments. Millennials & Gen Z (A) and Ingredient-Literate Consumers (A-) are the primary personas driving these demands, seeking transparency and proven efficacy. The subcategory mix reveals that Chemical Peels/Liquids dominate with 45.2% share, followed by Enzyme Exfoliants at 20.8%, and a growing interest in Scalp Exfoliants at 12.5%. This indicates a clear opportunity for brands to develop multi-benefit, gentle liquid formulations that cater to both facial and emerging 'skinification of hair' needs, while actively supporting skin barrier health.

Distribution for chemical exfoliants is concentrated across specialized beauty retailers, which command the largest share at 28.5%. Drugstores (22.1%) and Supermarkets/Mass Merchandisers (20.7%) also hold significant portions, reflecting the category's broad appeal across different price points. Online D2C/Brand Sites represent a substantial 18.9% of the market, highlighting the importance of direct consumer engagement and digital sales channels, especially for emerging brands. Professional/Medical Spas account for 7.8%, catering to a premium, treatment-oriented segment. The margin structure indicates a strong position for brands, with brand margins ranging from 52-57%, while retailer margins are between 38-43%. This balance suggests that brands retain significant negotiating power, but retailers are also incentivized to carry these products. The robust online presence and specialized retail dominance underscore a consumer base that values both convenience and expert curation.

The chemical exfoliant category faces several notable risks that demand strategic attention. Inflation sensitivity is graded C-, indicating moderate susceptibility to price increases, which could impact consumer purchasing decisions. Trade-down risk is relatively low at D+, suggesting brand loyalty or perceived efficacy outweighs immediate cost concerns for many consumers. However, the most acute risk is the strong private label momentum, graded A-. This signifies that private label offerings are increasingly competitive, potentially capturing market share by providing similar efficacy at lower price points. Compounding this is a 'High' policy watch level, primarily driven by increasing scrutiny and impending bans on ingredients like PFAS. Practitioners must prioritize transparent, clean-label formulations and invest in clear communication of product benefits to mitigate private label encroachment, while proactively preparing for evolving regulatory landscapes to avoid compliance issues.

The market environment for chemical exfoliants is characterized by a 'High' policy watch level, primarily due to ongoing regulatory scrutiny of ingredients like PFAS and broader ingredient safety. This necessitates proactive monitoring and potential reformulation efforts from brands. Shopper sentiment remains 'Positive,' driven by informed consumers who are actively seeking gentle efficacy and long-term skin health benefits. Upcoming consumer events will significantly influence sales trajectories: Back-to-School provides an opportunity to target younger demographics with acne-focused or preventative solutions. Black Friday/Cyber Monday and the Christmas/Holiday Season are critical periods for promotional activities, gift sets, and premium offerings, historically driving substantial sales spikes. Strategic planning for the next quarter must integrate these events with the prevailing consumer sentiment for gentle, effective, and transparent products, while also ensuring compliance with anticipated policy changes.

The chemical exfoliant category is in a transformative phase, driven by informed consumers demanding gentle, effective, and barrier-supporting formulations. Brands must prioritize innovation in PHAs, enzyme-based solutions, and buffered AHAs to align with top current trends and consumer jobs-to-be-done. With strong private label momentum and a high policy watch on ingredients like PFAS, transparency and clean-label formulations are not just preferences but necessities. As we approach the critical Black Friday/Cyber Monday and Holiday Season, brands should leverage promotional strategies that highlight product efficacy, ingredient integrity, and long-term skin health benefits to capture demand from a positive yet discerning consumer base.

This report is powered by Simporter's multi-source intelligence platform, which cross-analyzes independent data channels including search traffic, social media, customer reviews, point-of-sale data, and product descriptions. No single data source is predictive on its own. By multi-sourcing across these channels, Simporter filters out noise and surfaces pattern-driven signals for more accurate market intelligence. Derived metrics such as growth rates, market position scores, and volatility indices are calculated from these cross-referenced base values.